Albert Sabin

Albert Bruce Sabin (August 26, 1906 – March 3, 1993) was a Polish-American medical researcher, virologist, and pediatrician renowned for developing the oral polio vaccine (OPV), a live-attenuated vaccine that revolutionized global efforts to eradicate poliomyelitis. Born in Bialystok, northeastern Poland (then part of the Russian Empire), Sabin immigrated to the United States with his family in 1921 at age 15, settling in New Jersey after an arduous 18-month journey. He earned his MD from New York University College of Medicine in 1931, following initial studies in dentistry, and began his career as a research associate there before advancing through key positions at Bellevue Hospital, the Lister Institute in London, and the Rockefeller Institute for Medical Research.

Sabin's groundbreaking work on polio began in the 1930s, when he demonstrated that the poliovirus is an enteric pathogen transmitted via fecal-oral and respiratory routes, and successfully cultured it in non-nervous human tissue, paving the way for vaccine development. In the 1950s, while at the University of Cincinnati's Children's Hospital Research Foundation, he focused on attenuating live polioviruses to create a safe, orally administered vaccine, testing strains on over 10,000 monkeys, 160 chimpanzees, himself, his family, and prison volunteers in Ohio. Field trials commenced in 1958–1959 across the Soviet Union (involving over 77 million people), Czechoslovakia (110,000 children), Mexico (200,000 individuals), and other sites, confirming the vaccine's safety and efficacy; the U.S. licensed the trivalent OPV in 1961, which soon supplanted Jonas Salk's injected inactivated vaccine due to its ease of administration, lower cost, and ability to induce mucosal immunity.

The impact of Sabin's OPV was profound, enabling mass immunization campaigns worldwide and contributing to the near-eradication of polio; by 1979, the last indigenous U.S. case occurred, and regions like the Americas (1994), Europe (2002), and Africa (2020) achieved polio-free status under the World Health Organization's Global Polio Eradication Initiative. Notably, Sabin refused to patent his vaccine, famously stating it belonged to the public, ensuring its affordability and widespread use that has saved over 300,000 lives annually and generated billions in global health savings. In his later career, he served as president of Israel's Weizmann Institute of Science (1970–1972), held distinguished professorships at the Medical University of South Carolina and Georgetown University, and consulted for the U.S. National Cancer Institute, while continuing advocacy for polio elimination until his death from heart failure in Washington, D.C. His contributions earned him the National Medal of Science in 1970 and posthumous honors, including commemorative stamps from several nations.